# Prognostic significance of histologic phenotype in periampullary adenocarcinomas

**Authors:** Hee-Sung Kim, Chang-Min Heo, Yoo-Shin Choi, Suk-Won Suh, Seung Eun Lee

PMC · DOI: 10.3389/fonc.2024.1407828 · Frontiers in Oncology · 2024-07-16

## TL;DR

This study finds that the histologic type of periampullary adenocarcinomas, specifically intestinal versus pancreatobiliary, is linked to different survival rates and tumor behaviors.

## Contribution

The study identifies clinicopathological differences and survival outcomes between intestinal and pancreatobiliary types of periampullary adenocarcinomas.

## Key findings

- Intestinal-type tumors were associated with better survival and less aggressive features compared to pancreatobiliary-type tumors.
- The 5-year overall survival rate was significantly higher for intestinal-type tumors (58.8%) than for pancreatobiliary-type tumors (20.4%).
- Curative resection was the only independent prognostic factor in multivariate analysis.

## Abstract

Periampullary adenocarcinomas typically exhibit either intestinal or pancreatobiliary (PB) differentiation, and the type of differentiation may be prognostically more important than the anatomic site of origin. This study aimed to evaluate prognostic significance of histological type of periampullary carcinomas.

Microscopic slides from 110 consecutive pancreatoduodenectomies performed between 2010 and 2020 were reviewed and classified as intestinal or PB type. Clinicopathological factors were compared between PB-(n=93) and intestinal-type (n=17) differentiation.

The intestinal type included significantly more patients with well-differentiated histology (35.3% vs. 11.8%, p=0.001) and fewer patients with perineural invasion (41.2% vs. 76.4%, p=0.029), advanced T stage (> T3; 41.2% vs.74.2%, p=0.007), and systemic recurrence (71.4% vs. 92.9%, p=0.005) than PB type. The 5-year-overall survival rate of intestinal-type was significantly higher than that of PB-type (58.8% vs. 20.4%, p=0.003). When pancreatic cancer was separately analyzed, the intestinal type showed the best 5-year-overall survival rate, with no significant difference between the PB types excluding PDAC and PDAC (39.4% vs. 19.2%, p=0.148). In multivariate analysis, curative resection (hazard ratio, 0.417; 95% CI, 0.219-0.792, p=0.008) was the only significant prognostic factor.

Although intestinal histologic phenotype was not an independent prognostic factor on multivariate analysis, it showed pathologic features associated with better survival, while the PB type showed more aggressive tumor biology and consequently worse survival. Further studies are needed to demonstrate the prognostic significance of histologic phenotype.

## Linked entities

- **Diseases:** pancreatic cancer (MONDO:0005192)

## Full-text entities

- **Diseases:** pancreatic cancer (MESH:D010190), Periampullary adenocarcinomas (MESH:D000230), perineural (MESH:D052958), tumor (MESH:D009369), periampullary carcinomas (MESH:D011125), PDAC (MESH:C537768)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11286735/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11286735/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC11286735/full.md

---
Source: https://tomesphere.com/paper/PMC11286735